Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

UN-recognised scholar awarded the prestigious TRI Annual PhD Award
2015-11-09

Dr Anneli Botha, winner of TRI Award for Best Doctoral Thesis.
Photo: Supplied

Two years after enrolling as a PhD candidate in the University of the Free State’s (UFS) Department of Political Studies and Governance, Dr Anneli Botha was awarded the annual Terrorism Research Initiative (TRI) Award for the 'Best Doctoral Thesis on Terrorism and Counter-Terrorism' (2014).

The TRI PhD award is a prestigious international honour, while terrorism as a scholarly venture remains a concentrated field. Dr Botha, one of the few women in this niche field, has proved to be an excellent asset. Her winning of the prestigious award was announced in its October 2015 issue of Perspectives on Terrorism (PT), a globally-circulated online journal, co-published by the European-based Terrorism Research Initiative and the America-based Center for Terrorism and Security Studies.

Based on the merit and relevance of her outstanding research, the United Nations Development Programme has appointed Dr Botha as a Consultant on Radicalisation. In addition, her PhD is to be published as a book in the United States of America early in 2016. She was appointed as a Research Associate at the University of the Free State at the beginning of this year.

An award-winning search for answers

Her thesis, titled “Radicalisation to Terrorism in Kenya and Uganda: a Political Socialisation Perspective”, tackled East African militancy, from an individualised perspective. Researchers in the past have neglected assessing details of the rebels’ childhoods. Dr Botha’s interviewed about 285 militants and their families. These individuals declared themselves openly as members of al-Shabaab and the Mombasa Republican Council (MRC) in Kenya, and the Allied Democratic Forces (ADF) and the Lord’s Resistance Army (LRA) in Uganda, at the time of the interviews.

Her doctoral dissertation provides significant information about factors that should be considered in the quest to counter and prevent terrorism. Her research shows conclusively that political socialisation begins with the family, and expands through peers, school, media, and earlier political experiences, culminating in the terrorist group.

Outstanding piece of scholarship

Dr Alex Schmid
, who is the editor of PT, TRI Award Jury chairman, and one of the most respected experts of terrorism, described Dr Botha’s research as an “outstanding piece of scholarship.”

Dr Botha attributed her success to her supervisors - Professors Theo Neethling and Hussein Solomon - as well as to the people in Kenya and Uganda.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept